ranitidine has been researched along with Chemotherapy-Induced Febrile Neutropenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borthakur, G; Brail, L; Chow, KH; Cooley, S; Jackson, K; Moonan, L; Odenike, O; Rizzieri, DA; Wang, X | 1 |
1 trial(s) available for ranitidine and Chemotherapy-Induced Febrile Neutropenia
Article | Year |
---|---|
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Anti-Ulcer Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Bone Marrow Cells; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Female; Glycogen Synthase Kinase 3; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Male; Maleimides; Middle Aged; Pain, Procedural; Pemetrexed; Protein Kinase Inhibitors; Ranitidine; Thrombocytopenia | 2016 |